CareRx Corporation
CRRX.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 68.92M | 67.68M | 66.05M | 62.40M | 65.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 68.92M | 67.68M | 66.05M | 62.40M | 65.85M |
| Cost of Revenue | 48.04M | 47.25M | 46.45M | 43.87M | 46.32M |
| Gross Profit | 20.88M | 20.44M | 19.60M | 18.53M | 19.53M |
| SG&A Expenses | 18.86M | 18.00M | 17.64M | 16.77M | 19.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -700.00 | 700.00 | -- | -- | -- |
| Total Operating Expenses | 66.91M | 65.24M | 64.09M | 60.64M | 65.69M |
| Operating Income | 2.01M | 2.44M | 1.97M | 1.76M | 161.40K |
| Income Before Tax | 728.10K | 1.13M | 405.50K | 158.20K | -1.58M |
| Income Tax Expenses | -16.34M | -- | -- | -- | 22.90K |
| Earnings from Continuing Operations | 17.06M | 1.13M | 405.50K | 158.20K | -1.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.06M | 1.13M | 405.50K | 158.20K | -1.60M |
| EBIT | 2.01M | 2.44M | 1.97M | 1.76M | 161.40K |
| EBITDA | 4.42M | 5.42M | 4.06M | 4.39M | 785.10K |
| EPS Basic | 0.27 | 0.02 | 0.01 | 0.00 | -0.03 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.01 | 0.01 | -0.01 |
| EPS Diluted | 0.27 | 0.01 | 0.01 | 0.00 | -0.03 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.01 | 0.01 | -0.01 |
| Average Basic Shares Outstanding | 62.85M | 62.99M | 63.00M | 62.73M | 60.93M |
| Average Diluted Shares Outstanding | 64.11M | 64.91M | 64.97M | 65.19M | 60.93M |
| Dividend Per Share | 0.01 | 0.01 | -- | -- | -- |
| Payout Ratio | 5.29% | -- | -- | -- | -- |